Follow
Uijin Kim
Uijin Kim
Department of Systems Biology, Yonsei University
Verified email at yonsei.ac.kr
Title
Cited by
Cited by
Year
Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants
BS Jeong, JS Cha, I Hwang, U Kim, J Adolf-Bryfogle, B Coventry, HS Cho, ...
MAbs 14 (1), 2021601, 2022
132022
A novel therapeutic anti-ErbB3, ISU104 exhibits potent antitumorigenic activity by inhibiting ligand binding and ErbB3 heterodimerization
M Hong, Y Yoo, M Kim, JY Kim, JS Cha, MK Choi, U Kim, K Kim, Y Sohn, ...
Molecular Cancer Therapeutics 20 (6), 1142-1152, 2021
72021
Catalytic DxD motif caged in Asx-turn and Met–aromatic interaction attenuates the pathogenic glycosylation of SseK2/NleB2 effectors
E Koh, U Kim, HS Cho
Scientific reports 12 (1), 19288, 2022
12022
The system can't perform the operation now. Try again later.
Articles 1–3